Indefinite Delivery Contract SPE2DB24D9246

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999.00, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This includes common medications such as antibiotics, pain relievers, and cardiovascular drugs, as well as specialized drugs and medical supplies like flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. Through this IDC and associated task orders, DMS Pharmaceutical Group provides both routine and critical pharmaceuticals to support the diverse medical requirements of the Department of Defense healthcare system.

The contract aims to establish a reliable supply chain for a wide array of pharmaceutical products to military medical facilities globally. As a woman-owned small business, DMS Pharmaceutical Group leverages its federal contracting status to secure direct awards for pharmaceutical Prime Vendor programs supporting the Department of Defense. This IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.